tiprankstipranks
Trending News
More News >
Sartorius Stedim Biotech (FR:DIM)
:DIM
France Market

Sartorius Stedim Biotech (DIM) Income Statement

Compare
21 Followers

Sartorius Stedim Biotech Income Statement

Last quarter (Q4 2025), Sartorius Stedim Biotech's total revenue was €772.20M, an increase of 2.78% from the same quarter last year. In Q4, Sartorius Stedim Biotech's net income was €47.30M. See Sartorius Stedim Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 2.97B€ 2.78B€ 2.78B€ 3.49B€ 2.89B
Gross Profit
€ 1.35B€ 1.21B€ 1.23B€ 1.82B€ 1.55B
Operating Expenses
€ 796.30M€ 836.10M€ 749.00M€ 764.10M€ 640.34M
Depreciation and Amortization
€ 318.10M€ 301.70M€ 237.60M€ 181.70M€ 141.56M
EBITDA
€ 867.10M€ 670.50M€ 755.70M€ 1.33B€ 811.96M
Operating Income
€ 549.00M€ 370.60M€ 484.50M€ 1.10B€ 912.67M
Other Income/Expenses
€ -175.80M€ -151.40M€ -83.40M€ 29.20M€ -265.95M
Pretax Income
€ 373.20M€ 219.20M€ 401.10M€ 1.13B€ 646.72M
Net Income
€ 265.60M€ 175.10M€ 309.70M€ 876.10M€ 414.40M
Per Share Metrics
Basic EPS
€ 2.73€ 1.81€ 3.36€ 9.51€ 4.50
Diluted EPS
€ 2.73€ 1.81€ 3.36€ 9.51€ 4.50
Weighted Average Shares Outstanding
97.30M 96.78M 92.16M 92.16M 92.18M
Weighted Average Shares Outstanding (Diluted)
97.30M 96.78M 92.16M 92.16M 92.18M
Currency in EUR

Sartorius Stedim Biotech Earnings and Revenue History